Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Genome Editing/Genome Engineering Market Expected To Expand Between 2025 And 2029?
The genome editing/genome engineering market has experienced significant expansion in recent years. It is forecast to increase from $8.62 billion in 2024 to $10.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.9%. The past growth in this sector is attributed to factors such as increasing research in genetics and genomics, a rise in genetic diseases, advancements in gene therapy, investments in biotechnology and life sciences, the potential for agricultural applications, and its use in model organisms.
The genome editing/genome engineering market is anticipated to grow significantly in the coming years. By 2029, it is forecast to reach a valuation of $20.64 billion, exhibiting a compound annual growth rate (CAGR) of 19.4%. This expansion during the forecast period is largely due to factors such as the advent of prime editing, increased attention on ethical and regulatory guidelines, wider use in drug discovery, its therapeutic capabilities for genetic conditions, tailored applications for gene function research, and rising engagement with epigenome editing. Key developments anticipated in this period encompass progress in Crispr technology, expanding therapeutic applications, the introduction of novel genome editing instruments, increased investments and collaborative ventures, improved delivery mechanisms, and the incorporation of artificial intelligence (AI) into genome editing design.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp
Which Factors And Drivers Are Influencing The Genome Editing/Genome Engineering Market In 2025?
The increasing prevalence of cancer and other genetic disorders is anticipated to drive the future growth of the genome editing/genome engineering market. Cancer involves certain body cells growing uncontrollably and spreading to other regions, a condition for which genome editing offers a rapid method to engineer immune cells and oncolytic viruses for therapeutic applications. For example, an article published by the World Health Organization (WHO), a Switzerland-based United Nations health agency, in February 2022, revealed that cancer accounted for nearly 10 million deaths, or approximately one in six deaths, globally, making it the leading cause of death worldwide. Additionally, a report from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in June 2022, indicated that 1,752,735 new cases of invasive cancer were reported in the US in 2019, including 863,830 women and 888,905 men. The incidence rate for all cancers was 439 per 100,000 people in the general population. Therefore, the heightened occurrence of cancer and various genetic disorders is a significant factor propelling the expansion of the genome editing and genome engineering market.
What Are The Major Segment Categories Driving The Genome Editing/Genome Engineering Market Growth?
The genome editing/genome engineeringmarket covered in this report is segmented –
1) By Product And Service: Reagents And Consumables; Software And systems; Services
2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects
Which Competitive Trends Are Defining The Genome Editing/Genome Engineering Market Structure?
Technological progress in gene editing is a key trend gaining traction in the genome editing/genome engineering market. Major companies operating in the genome editing/genome engineering market are concentrating on developing innovative technology solutions to improve their standing. For instance, in May 2022, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research university focused on evolutionary biology, unveiled a swift and effective method for editing genes in insects. Direct parental CRISPR (DIPA-CRISPR), a simple and effective method, involves injecting materials into developing eggs in female adults rather than into embryos. This novel technique enables researchers to avoid the microinjection of CRISPR material into insect embryos.
Which Leading Players Are Enhancing Their Genome Editing/Genome Engineering Market Presence Worldwide?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Genome Editing/Genome Engineering Industry?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Genome Editing/Genome Engineering Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp
Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2025, By The Business Research Company
Gene Editing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Cell And Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model